November 20th, 2009 in Treatment
Before we learned that Artesunate might inhibit XMRV via NF Kappa B inhibition in August of 2009, we were aware that Artesunate was a known inhibitor of all known human herpes viruses against which it has been tested as well as HIV. I was first introduced to Artesunate by a prominent Autism expert at a medical conference who finds it helpful in Autism. We were also impressed that Artesunate and its relative Wormwood, using SL administration on the echo table, produced the most powerful ablation of oxygen toxicity as well as the ablation of other echo terrain map (ETM) backflashes than any other therapy we have ever used. Both Artesunate and Wormwood will do this in 30 seconds.
April 15th, 2009 in Treatment
This treatment update discusses the uses and various strategies to improve the effectiveness of cell signaling factors based on actual clinical examples and patient experiences. Both positive and negative results are discussed and practical solutions to improve outcomes are detailed.
April 13th, 2009 in Treatment
This discussion explores the potential complications of Artesunate with two examples cited in patients.
April 12th, 2009 in Treatment
In this discussion, Dr. Cheney explores the opposite approaches of anti-oxidative vs. pro-oxidative therapies. It is important to recognize that both may be useful but in the highly oxidizing environment of CFS, one may be more appropriate than the other and much safer.